Basic info
Industry
pharmaceutical manufacturing
Sectors
Pharmaceutical
Biotechnology
Liver disease
Cancer
Translational medicine
Innovative therapeutics
Hepatic fibrosis
Health Care
Antivirals
Drug R&D
Precision medicine
Liver cancer
Drug discovery
NAFLD/NASH
HBV
Disease prevention
HCV
Date founded
2014
Funding rounds raised
Total raised
$5.2M
from 1 investors over 1 rounds
H
Hepanova, Inc. raised $5.2M on January 30, 2019
Investors: Shenzhen Capital Group Co., Ltd